JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
EXAS
3276
PUT
DELISTED
Exact Sciences
EXAS
| $1.73M | ﹤0.01% |
+20,000
| New | +$1.7M |
2019 Q1
0 quarters
|
|
3277
Digi International
DGII
$2.81B
| $1.73M | ﹤0.01% |
136,662
-54,546
| -29% | -$681K |
2015 Q1
16 quarters
|
|
|
ADAP
3278
DELISTED
Adaptimmune Therapeutics
ADAP
| $1.73M | ﹤0.01% |
402,354
-33,924
| -8% | -$158K |
2016 Q3
10 quarters
|
|
|
CMBT
3279
CMB.TECH NV
CMBT
$5.71B
| $1.73M | ﹤0.01% |
211,770
+203,662
| +2,512% | +$1.6M |
2017 Q3
6 quarters
|
|
3280
CALL
APA Corp
APA
$15.5B
| $1.72M | ﹤0.01% |
49,700
-17,000
| -25% | -$554K |
2017 Q2
7 quarters
|
|
3281
Merit Medical Systems
MMSI
$5.07B
| $1.72M | ﹤0.01% |
27,875
+7,737
| +38% | +$439K |
2016 Q2
11 quarters
|
|
|
NE
3282
DELISTED
Noble Corporation
NE
| $1.72M | ﹤0.01% |
598,759
-1,816,301
| -75% | -$5.66M |
2013 Q2
23 quarters
|
|
3283
West Bancorporation
WTBA
$503M
| $1.72M | ﹤0.01% |
83,000
-286
| -0.3% | -$6.1K |
2013 Q2
23 quarters
|
|
|
DPLO
3284
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $1.72M | ﹤0.01% |
295,094
+221,009
| +298% | +$2.28M |
2015 Q3
14 quarters
|
|
3285
Pacer Trendpilot US Large Cap ETF
PTLC
$3.39B
| $1.71M | ﹤0.01% |
58,322
+16,243
| +39% | +$469K |
2018 Q4
1 quarter
|
|
3286
FormFactor
FORM
$11B
| $1.71M | ﹤0.01% |
106,408
-51,972
| -33% | -$784K |
2017 Q3
6 quarters
|
|
|
AMAG
3287
DELISTED
AMAG Pharmaceuticals
AMAG
| $1.71M | ﹤0.01% |
132,911
-846,765
| -86% | -$12.6M |
2013 Q2
23 quarters
|
|
3288
iShares Mortgage Real Estate ETF
REM
$443M
| $1.71M | ﹤0.01% |
39,407
+13,378
| +51% | +$574K |
2016 Q2
11 quarters
|
|
|
OCSI
3289
DELISTED
Oaktree Strategic Income Corporation
OCSI
| $1.7M | ﹤0.01% |
210,371
-75,843
| -26% | -$632K |
2014 Q3
18 quarters
|
|
3290
Genesco
GCO
$391M
| $1.7M | ﹤0.01% |
37,388
+6,467
| +21% | +$296K |
2013 Q2
23 quarters
|
|
3291
Marcus Corp
MCS
$815M
| $1.7M | ﹤0.01% |
42,526
-3,255
| -7% | -$135K |
2016 Q1
12 quarters
|
|
3292
Dorian LPG
LPG
$2.42B
| $1.69M | ﹤0.01% |
263,866
+84,998
| +48% | +$498K |
2016 Q4
9 quarters
|
|
|
FLXN
3293
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $1.69M | ﹤0.01% |
135,494
-8,785
| -6% | -$117K |
2015 Q4
13 quarters
|
|
3294
Interactive Brokers
IBKR
$41B
| $1.69M | ﹤0.01% |
130,312
-15,696
| -11% | -$206K |
2013 Q2
23 quarters
|
|
|
SRCI
3295
DELISTED
SRC Energy Inc
SRCI
| $1.69M | ﹤0.01% |
329,771
+108,920
| +49% | +$533K |
2015 Q4
13 quarters
|
|
3296
PUT
Alnylam Pharmaceuticals
ALNY
$30B
| $1.68M | ﹤0.01% |
+18,000
| New | +$1.51M |
2019 Q1
0 quarters
|
|
3297
Lattice Semiconductor
LSCC
$19.1B
| $1.68M | ﹤0.01% |
140,693
+91,353
| +185% | +$912K |
2016 Q4
9 quarters
|
|
|
IMDZ
3298
DELISTED
Immune Design Corp.
IMDZ
| $1.68M | ﹤0.01% |
286,375
-242,589
| -46% | -$826K |
2014 Q3
18 quarters
|
|
3299
iShares US Utilities ETF
IDU
$1.41B
| $1.67M | ﹤0.01% |
22,722
-490,676
| -96% | -$34.6M |
2013 Q2
23 quarters
|
|
3300
KB Financial Group
KB
$43.8B
| $1.67M | ﹤0.01% |
45,161
+1,444
| +3% | +$57.7K |
2013 Q3
22 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.